Repligen Corporation (RGEN)

Repligen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	41.58	185.96	128.29	59.93	21.41
Depreciation & Amortization	68.09	50.99	38.45	27.07	20.87
Share-Based Compensation	25.58	27.32	27.5	17.01	12.85
Other Operating Activities	-21.32	-92.18	-75.22	-41.38	12.09
Operating Cash Flow	113.92	172.08	119.02	62.63	67.22
Operating Cash Flow Growth	-33.80%	44.59%	90.05%	-6.83%	105.11%
Capital Expenditures	-38.99	-133.35	-71.28	-26.34	-23.15
Acquisitions	-186.64	0	-149.89	-175.04	-182.15
Change in Investments	102.32	-100	0	0	0
Other Investing Activities	0.03	0.11	-	-	-
Investing Cash Flow	-123.28	-233.24	-221.17	-201.39	-205.31
Share Issuance / Repurchase	-13.31	3.71	3.88	305.93	321.88
Debt Issued / Paid	282.84	0	0	0	163.48
Other Financing Activities	-20.57	-17.04	-2.92	-0.01	-0.49
Financing Cash Flow	248.96	-13.34	0.96	305.92	484.87
Exchange Rate Effect	-11.74	-5.87	-12.29	12.73	-3.19
Net Cash Flow	227.87	-80.36	-113.48	179.89	343.59
Free Cash Flow	74.93	38.74	47.74	36.28	44.06
Free Cash Flow Growth	93.43%	-18.86%	31.58%	-17.66%	120.44%
Free Cash Flow Margin	11.73%	4.83%	7.12%	9.91%	16.30%
Free Cash Flow Per Share	1.34	0.70	0.87	0.69	0.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).